Yunus Karakoc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yunus Karakoc has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Seher Tanrikulu
Department of Endocrinology, Acibadem Atasehir Hospital, Istanbul, Turkey
2 shared publications - Sena Ebru Caglar
Hamidiye Faculty of Medicine, Department of Physiology, University of Health Sciences, Istanbul, Türkiye
2 shared publications - Abdullah Sarı1 shared publication
- Aise Rumeysa Mazi
Department of Biophysics, Hamidiye Faculty of Medicine, University of Health Sciences
1 shared publication - Alev Kural
Department of Clinical Chemistry, Department of Biochemistry University of Health Sciences, Bakirköy Dr. Sadi Konuk Training and Research Hospital İstanbul Türkiye
1 shared publication - Alpaslan Tanoglu
Department of Internal Medicine, Division of Gastroenterology, Bahçeşehir University, Istanbul, Turkey
1 shared publication
Latest Publications
- Open Access
- 12 February 2026
- Published by Academician Publishing
Biyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- 12 February 2026
- Published by Academician Publishing
Open AccessBiyofiziksel Perspektifle Fizik Tedavi Modaliteleri
- 12 February 2026
- Published by Academician Publishing
- p. 1-8
Fizik Tedavi Modalitelerine İlişkin Biyofiziksel Temel Kavramlar
- 12 February 2026
- Published by Academician Publishing
- p. 1-8
Fizik Tedavi Modalitelerine İlişkin Biyofiziksel Temel Kavramlar
- Open Access
- 20 March 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-10
Investigation of hemorheology in patients with hyperthyroidism via blood viscosity, erythrocyte deformability and aggregation
Hyperthyroidism’s impact on cardiovascular, hematopoietic systems and metabolism might lead to hemorheological changes. This study aimed to investigate the changes in hemorheological properties via erythrocyte deformability and aggregation, whole blood viscosity (WBV) and plasma viscosity (PV) in hyperthyroid patients. The effect of anti-thyroid treatment on hemorheology was also studied. Thirty-six patients with overt hyperthyroidism, 19 patients with subclinical hyperthyroidism and 66 controls were included in the study. Hematocrit, erythrocyte deformability and aggregation, plasma and whole blood viscosity values were measured before treatment. Hemorheological parameters of the patients were compared with the control. Before and after treatment results of overt hyperthyroidism were analyzed. Methimazole was given as anti-thyroid treatment. Deformability and aggregation measurements were conducted using a laser ektacytometer (LORRCA) while viscosity measurements were performed with a cone-plate viscometer (Brookfield DV-III). The maximum elongation index (EImax) decreased significantly from 0.664 (0.01) pre-treatment to 0.657 (0.01) post-treatment (p = 0.04). The aggregation index was significantly higher in both the subclinical hyperthyroidism group [68.05 (7.66), p = 0.001] and the overt hyperthyroidism group [66.78 (8.815), p = 0.001] compared to the control group. Additionally, the aggregation half-time was significantly shorter in the subclinical hyperthyroidism group [1.9 (1.21–2.27), p = 0.001] and the overt hyperthyroidism group [1.91 (1.43–2.46), p = 0.001] relative to the control group. The hemorheological status of patients was influenced by excessive thyroid hormones in both subclinical and overt hyperthyroidism groups. Additionally, anti-thyroid therapy with methimazole may play a role in the observed decrease in the maximum elongation index following treatment.
- 20 March 2025
- Published by Springer Nature in Thyroid Research
- Vol. 18 (1) , 1-10
Open AccessInvestigation of hemorheology in patients with hyperthyroidism via blood viscosity, erythrocyte deformability and aggregation
Hyperthyroidism’s impact on cardiovascular, hematopoietic systems and metabolism might lead to hemorheological changes. This study aimed to investigate the changes in hemorheological properties via erythrocyte deformability and aggregation, whole blood viscosity (WBV) and plasma viscosity (PV) in hyperthyroid patients. The effect of anti-thyroid treatment on hemorheology was also studied. Thirty-six patients with overt hyperthyroidism, 19 patients with subclinical hyperthyroidism and 66 controls were included in the study. Hematocrit, erythrocyte deformability and aggregation, plasma and whole blood viscosity values were measured before treatment. Hemorheological parameters of the patients were compared with the control. Before and after treatment results of overt hyperthyroidism were analyzed. Methimazole was given as anti-thyroid treatment. Deformability and aggregation measurements were conducted using a laser ektacytometer (LORRCA) while viscosity measurements were performed with a cone-plate viscometer (Brookfield DV-III). The maximum elongation index (EImax) decreased significantly from 0.664 (0.01) pre-treatment to 0.657 (0.01) post-treatment (p = 0.04). The aggregation index was significantly higher in both the subclinical hyperthyroidism group [68.05 (7.66), p = 0.001] and the overt hyperthyroidism group [66.78 (8.815), p = 0.001] compared to the control group. Additionally, the aggregation half-time was significantly shorter in the subclinical hyperthyroidism group [1.9 (1.21–2.27), p = 0.001] and the overt hyperthyroidism group [1.91 (1.43–2.46), p = 0.001] relative to the control group. The hemorheological status of patients was influenced by excessive thyroid hormones in both subclinical and overt hyperthyroidism groups. Additionally, anti-thyroid therapy with methimazole may play a role in the observed decrease in the maximum elongation index following treatment.
- Open Access
- 2 October 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (6) , 727-738
Ektacytometric examination of red blood cells’ morphodynamical features in diabetic nephropathy patients
Objectives: Diabetic nephropathy (DN), the primary cause of end-stage renal disease, is associated with chronic hyperglycemia and elevated blood pressure. This study investigates the correlation between DN and changes in hemorheology, which involves blood flow properties. Methods: At the University of Health Sciences in Istanbul, Türkiye, erythrocyte deformability, aggregation, and viscosity were measured using advanced ektacytometry (Lorrca ® Maxsis) on blood samples from 31 healthy individuals, 41 diabetic patients, and 45 patients with diabetic nephropathy from University of Health Sciences Haydarpasa Numune Training and Research Hospital. All hematocrit values were standardized to 40 %. Results: Deformability of red blood cells (RBCs), indicated by the elongation index at shear stresses from 0 to 30 Pa, significantly decreased in the diabetic nephropathy group compared to diabetic patients without nephropathy and healthy controls (mean min-max SD: 0.650 (0.63–0.67) vs. 0.659 (0.64–0.68) and 0.642 (0.62–0.66), respectively; p<0.01). RBC aggregation significantly increased in the diabetic nephropathy group (mean min-max SD: 77.52 (57.84–90.7) vs. 69.96 (53.13–80.53) in controls; p<0.01), and plasma viscosity was also higher (mean min-max SD: 1.48 (1.27–2.02) mPa·s vs. 1.34 (1.22–1.72) mPa·s in controls; p<0.001). Conclusions: Our findings demonstrate marked hemorheological changes in diabetic nephropathy patients. These changes suggest that evaluating RBC deformability, aggregation, and viscosity is critical for developing therapeutic strategies aimed at reducing vascular complications and preventing tissue damage in diabetics.
- 2 October 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (6) , 727-738
Open AccessEktacytometric examination of red blood cells’ morphodynamical features in diabetic nephropathy patients
Objectives: Diabetic nephropathy (DN), the primary cause of end-stage renal disease, is associated with chronic hyperglycemia and elevated blood pressure. This study investigates the correlation between DN and changes in hemorheology, which involves blood flow properties. Methods: At the University of Health Sciences in Istanbul, Türkiye, erythrocyte deformability, aggregation, and viscosity were measured using advanced ektacytometry (Lorrca ® Maxsis) on blood samples from 31 healthy individuals, 41 diabetic patients, and 45 patients with diabetic nephropathy from University of Health Sciences Haydarpasa Numune Training and Research Hospital. All hematocrit values were standardized to 40 %. Results: Deformability of red blood cells (RBCs), indicated by the elongation index at shear stresses from 0 to 30 Pa, significantly decreased in the diabetic nephropathy group compared to diabetic patients without nephropathy and healthy controls (mean min-max SD: 0.650 (0.63–0.67) vs. 0.659 (0.64–0.68) and 0.642 (0.62–0.66), respectively; p<0.01). RBC aggregation significantly increased in the diabetic nephropathy group (mean min-max SD: 77.52 (57.84–90.7) vs. 69.96 (53.13–80.53) in controls; p<0.01), and plasma viscosity was also higher (mean min-max SD: 1.48 (1.27–2.02) mPa·s vs. 1.34 (1.22–1.72) mPa·s in controls; p<0.001). Conclusions: Our findings demonstrate marked hemorheological changes in diabetic nephropathy patients. These changes suggest that evaluating RBC deformability, aggregation, and viscosity is critical for developing therapeutic strategies aimed at reducing vascular complications and preventing tissue damage in diabetics.